Triathlon Medical Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Triathlon Medical Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 1, 2015	CoLucid Pharmaceuticals	$37.0M Series C	Dr. Luc Marengere	Cincy Tech, Domain Associates, Kleiner Perkins, Versant Ventures, Auriga Partners, Care Capital, Martin Edwards, Pappas Ventures, Pearl Street Venture Funds
Apr 23, 2014	Aerpio Pharmaceuticals	$22.0M Other Equity	Chau Khuong	Athenian Venture Partners, dRx Capital, Kearny Venture Partners, Satter Investment Management, Venture Investors
Nov 1, 2013	Aerpio Pharmaceuticals	$36.0M Series A	Muneer A. Satter	Cincy Tech, Athenian Venture Partners, dRx Capital, Kearny Venture Partners, Venture Investors
Oct 17, 2012	Tolera Therapeutics	$5.5M Series B	Robert Hackenberg	SWMF Life Science Fund
Aug 30, 2012	Aerpio Pharmaceuticals	$27.0M Series A	Campbell Murray	AgeChem, Athenian Venture Partners, Kearny Venture Partners, Venture Investors
Jul 16, 2012	Juventas Therapeutics	$22.2M Series B	Triathlon Medical Ventures	Early Stage Partners, Fletcher Spaght Ventures, Glengary, Global Cardiovascular Innovation Center, Reservoir Venture Partners, Takeda Ventures, Tri-State Growth Fund, Venture Investors
May 1, 2012	Mitralign	$35.0M Series D	Forbion	4See Ventures, Giza Venture Capital, Johnson & Johnson Innovation, Medtronic, Oakwood Medical Investors, Orchestra Medical Ventures, Oxford Bioscience Partners, Palisade Capital Management, Saints Capital
Jan 9, 2012	Akebia Therapeutics	$4.1M Series B Extension	—	AgeChem, Athenian Venture Partners, dRx Capital, Kearny Venture Partners, Sigvion Capital, Venture Investors
Aug 30, 2011	CoLucid Pharmaceuticals	$7.5M Other Equity	—	Care Capital, Domain Associates, Art Pappas, Pearl Street Venture Funds
Apr 1, 2011	Akebia Therapeutics	$22.0M Series B	Novartis, Venture Investors	Cincy Tech, AgeChem, Athenian Venture Partners, Kearny Venture Partners, Sigvion Capital
Jul 1, 2009	Akebia Therapeutics	$25.0M Series A	dRx Capital, Venture Investors	Cincy Tech, Athenian Venture Partners, Kearny Venture Partners, Sigvion Capital, John M. Rice